RA Capital Healthcare Fund LP, Director, 10% Owner at Janux Therapeutics, Inc. (JANX), bought 1,648,082 shares at $30.78 ($50.7M) on 2025-03-06, disclosed to the SEC on 2025-03-07.
Open-market purchase of $50.7M JANX by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.56 | 304,287 | $9.3M | 18.3% |
| 2 | $30.56 | 304,287 | $9.3M | 18.3% |
| 3 | $31.30 | 37,455 | $1.2M | 2.3% |
| 4 | $31.30 | 37,455 | $1.2M | 2.3% |
| 5 | $30.78 | 372,093 | $11.5M | 22.6% |
| 6 | $30.78 | 372,093 |
| $11.5M |
| 22.6% |
| 7 | $31.02 | 110,206 | $3.4M | 6.7% |
| 8 | $31.02 | 110,206 | $3.4M | 6.7% |
| Total | $30.75 avg | 1,648,082 | $50.7M | 100% |
| Filing → |
| FULC | SELL | 2025-12-10 | $116.8M | — | Filing → |
| PEPG | BUY | 2025-09-30 | $30.0M | — | Filing → |
| TYRA | BUY | 2025-06-11 | $3.8M | — | Filing → |